|1.||Ohashi, Yuji: 2 articles (12/2003 - 12/2002)|
|2.||Fukuhara, Hiroshi: 2 articles (12/2003 - 12/2002)|
|3.||Hata, Tadashi: 2 articles (12/2003 - 12/2002)|
|4.||Kobayashi, Katsuhiro: 2 articles (12/2003 - 12/2002)|
|5.||Sekine, Akiko: 1 article (12/2002)|
|6.||Uekusa, Hidehiro: 1 article (12/2002)|
|7.||Kawamoto, Isao: 1 article (12/2002)|
03/01/1998 - "In murine respiratory infection models, the efficacy of CS-834 reflected not only its potent in vitro activity but also the high levels present in the lungs."
12/01/1997 - "The in vivo efficacy of CS-834 was evaluated in murine systemic infections caused by 16 strains of gram-positive and -negative pathogens. "
10/01/1998 - "Against systemic infections in mice caused by various bacteria, CS-834 showed an excellent protective effect and its in-vivo efficacy correlated well with the in-vitro activity of R-95867. "
12/01/1997 - "The efficacy of CS-834 was in many cases superior to those of cefteram pivoxil, cefpodoxime proxetil, cefdinir, and cefditoren pivoxil, especially against infections caused by S. "
01/01/1998 - "Efficacy of CS-834 against experimental pneumonia caused by penicillin-susceptible and -resistant Streptococcus pneumoniae in mice."
12/01/1997 - "Among the drugs tested, CS-834 showed the highest efficacy against experimental pneumonia in mice caused by penicillin-resistant S. "
01/01/1998 - "The efficacy of CS-834, a novel oral carbapenem, was assessed by using a murine model of pneumonia caused by penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae and was compared with those of oral cephems, i.e., cefteram pivoxil, cefpodoxime proxetil, cefdinir, and cefditoren pivoxil. "
03/01/1998 - "Against methicillin-resistant staphylococci, enterococci, Serratia marcescens, Burkholderia cepacia, Stenotrophomonas maltophilia, and Acinetobacter calcoaceticus, R-95867 showed activity comparable to or slightly less than that of imipenem, with MIC90s ranging from 2 to >128 microg/ml. The in vivo efficacy of oral CS-834 against experimental mouse septicemia caused by gram-positive and gram-negative bacteria was better than that of comparative drugs. "
|4.||Bacterial Infections (Bacterial Infection)
|5.||Urinary Tract Infections (Urinary Tract Infection)
|2.||cefditoren pivoxil (Spectracef)
|4.||cefpodoxime proxetil (Vantin)